Session Details
[2S03m]Bidirectional translational research to elucidate the pathophysiology of psychiatric and neurological disorders
Tue. Mar 18, 2025 8:30 AM - 10:20 AM JST
Tue. Mar 18, 2025 11:30 PM - 1:20 AM UTC
Tue. Mar 18, 2025 11:30 PM - 1:20 AM UTC
Room 3
Oranizers :Tomoyuki Furuyashiki (Kobe University Graduate School of Medicine) and Masaki Fukata (Nagoya University Graduate School of Medicine)
Sponsored by : AMED Brain Mechanisms and Integrated Technologies for Mental Health and Disease Studies (Brain/MINDS Health and Diseases) Project
Psychiatric and neurological disorders significantly impact both individual lives and society. Despite their prevalence, the reduction in patient numbers and the establishment of fundamental treatments remain unachieved. Addressing this challenge necessitates the creation of a cohesive research framework that both deciphers the molecular underpinnings and the operational principles of the brain in these diseases, thereby connecting basic research discoveries directly to clinical practices. Since FY2021, the AMED has spearheaded the Brain/MINDS Health and Diseases Project. For almost four years, this initiative has supported a broad spectrum of basic and clinical research endeavors, from uncovering the mechanisms behind psychiatric and neurological diseases to applying these findings in practical settings. This effort has fostered the development of a dynamic research ecosystem, enhancing collaboration across these studies. Consequently, it has illuminated the hierarchical and longitudinal pathophysiology of psychiatric and neurological disorders, spanning from molecular aspects to synapses, neural circuits, and beyond to brain-periphery interplay. This advancement opens up new avenues for diagnosing and treating these conditions based on their pathophysiology. In this symposium, we aim to present the cutting-edge findings from the AMED Brain/MINDS Health and Diseases Project and discuss the interdisciplinary research necessary to overcome these disorders.
[[OD]2S03m-1]Advancements in Elucidating the Pathogenesis of Mental and Neurological Disorders and the Development of Treatments
○Kozo Kaibuchi (Fujita Health University)
[[OD]2S03m-2]Pharmacological research to overcome drug addiction
○Taku Nagai (Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University)
[[OD]2S03m-3]α-Synuclein aggregation and propagation in
Parkinson’s disease
○Taku Hatano, Nobutaka Hattori (Department of Neurology, Juntendo University Faculty of Medicine)
[2S03m-4]Elucidating the pathophysiology of the paraventricular thalamic nucleus in bipolar disorder
○Tadafumi Kato (Juntendo University)
[[OD]2S03m-5]Inflammatory Mechanisms of Chronic Stress-Induced Brain Functional Alterations
○Tomoyuki Furuyashiki (Kobe University)